Hepatocellular carcinoma decreases the effectiveness of hepatitis C antiviral treatment: Do direct-acting antiviral regimens matter?
- PMID: 29194694
- DOI: 10.1002/hep.29701
Hepatocellular carcinoma decreases the effectiveness of hepatitis C antiviral treatment: Do direct-acting antiviral regimens matter?
Comment in
Comment on
-
Challenges in treatment of hepatitis C among patients with hepatocellular carcinoma.Hepatology. 2017 Aug;66(2):661-663. doi: 10.1002/hep.29126. Epub 2017 Jun 24. Hepatology. 2017. PMID: 28211073 No abstract available.
-
Unexpected viral relapses in hepatitis C virus-infected patients diagnosed with hepatocellular carcinoma during treatment with direct-acting antivirals.Hepatology. 2017 Sep;66(3):992-994. doi: 10.1002/hep.29181. Epub 2017 Jul 18. Hepatology. 2017. PMID: 28370176 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical